Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous sequelae following etomidate.

M Zacharias, R S Clarke, J W Dundee

    British Journal of Anaesthesia
    |August 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intravenous anesthesia--Chairman's opening and closing remarks. 1962.

    International anesthesiology clinics·1999
    Same author

    Antiemetic or antinauseant effect of ondansetron?

    Anesthesia and analgesia·1992
    Same author

    Is ondansetron a less effective antiemetic against moderately emetic as compared with highly emetic chemotherapy?

    British journal of clinical pharmacology·1992
    Same author

    P6 acupressure and postoperative vomiting.

    British journal of anaesthesia·1992
    Same author

    Advantages and problems with benzodiazepine sedation.

    Anesthesia progress·1992
    Same author

    Safety of alcohol after midazolam.

    Anesthesia and analgesia·1991

    The formulation of etomidate significantly impacts venous sequelae risk. Propylene glycol formulations showed the highest incidence of these side effects in patients post-operation.

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Surgical Complications

    Background:

    • Etomidate is an anesthetic agent used in surgical procedures.
    • Venous sequelae are potential complications following drug administration.
    • Understanding formulation-specific risks is crucial for patient safety.

    Purpose of the Study:

    • To evaluate the incidence of venous sequelae associated with different etomidate formulations.
    • To identify factors influencing the development of venous sequelae after etomidate administration.

    Main Methods:

    • Observational study involving 500 patients receiving one of three etomidate formulations.
    • Assessment of venous sequelae on the 2nd and 3rd days post-operation.
    • Analysis of formulation type, total dose, and pain on injection as influencing factors.

    Related Experiment Videos

    Main Results:

    • Overall venous sequelae frequency was 8% or higher.
    • The propylene glycol formulation exhibited the highest sequelae rate at 23%.
    • Drug formulation and total dose were key factors; pain on injection was not related.

    Conclusions:

    • Etomidate formulation is a critical determinant of venous sequelae.
    • Propylene glycol-based etomidate formulations are associated with increased risk.
    • Optimizing etomidate formulation and dosage can mitigate postoperative complications.